NO170415C - Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske katekolderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske katekolderivater

Info

Publication number
NO170415C
NO170415C NO863835A NO863835A NO170415C NO 170415 C NO170415 C NO 170415C NO 863835 A NO863835 A NO 863835A NO 863835 A NO863835 A NO 863835A NO 170415 C NO170415 C NO 170415C
Authority
NO
Norway
Prior art keywords
catalog
derivatives
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO863835A
Other languages
English (en)
Other versions
NO170415B (no
NO863835L (no
NO863835D0 (no
Inventor
Michel Follet
Marc Bonato
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of NO863835D0 publication Critical patent/NO863835D0/no
Publication of NO863835L publication Critical patent/NO863835L/no
Publication of NO170415B publication Critical patent/NO170415B/no
Publication of NO170415C publication Critical patent/NO170415C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
NO863835A 1985-09-26 1986-09-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske katekolderivater NO170415C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858523776A GB8523776D0 (en) 1985-09-26 1985-09-26 Catechol derivatives

Publications (4)

Publication Number Publication Date
NO863835D0 NO863835D0 (no) 1986-09-25
NO863835L NO863835L (no) 1987-03-27
NO170415B NO170415B (no) 1992-07-06
NO170415C true NO170415C (no) 1992-10-14

Family

ID=10585770

Family Applications (2)

Application Number Title Priority Date Filing Date
NO863835A NO170415C (no) 1985-09-26 1986-09-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske katekolderivater
NO863834A NO165238C (no) 1985-09-26 1986-09-25 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive katekolderivater.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO863834A NO165238C (no) 1985-09-26 1986-09-25 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive katekolderivater.

Country Status (28)

Country Link
US (2) US4699919A (no)
JP (2) JPS6284055A (no)
AR (2) AR242559A1 (no)
AT (2) AT402070B (no)
BE (2) BE905433A (no)
CA (2) CA1278299C (no)
CH (2) CH668421A5 (no)
DE (2) DE3632841A1 (no)
DK (2) DK165115C (no)
DZ (2) DZ990A1 (no)
ES (2) ES2001705A6 (no)
FI (2) FI84480C (no)
FR (4) FR2587702B1 (no)
GB (3) GB8523776D0 (no)
HK (2) HK91289A (no)
IE (2) IE59478B1 (no)
IT (2) IT1235761B (no)
LU (2) LU86590A1 (no)
MA (2) MA20780A1 (no)
MY (2) MY103521A (no)
NL (2) NL189334C (no)
NO (2) NO170415C (no)
OA (2) OA08417A (no)
PT (2) PT83437B (no)
SE (2) SE467053B (no)
SG (1) SG65889G (no)
TN (2) TNSN86135A1 (no)
ZA (2) ZA866905B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927629A (en) * 1987-12-17 1990-05-22 Huntington Medical Research Institutes Relaxation of smooth vascular muscle
WO1999024038A1 (en) 1997-11-07 1999-05-20 Johns Hopkins University Methods for treatment of disorders of cardiac contractility
US20100075926A1 (en) * 2008-07-23 2010-03-25 Li-Huei Tsai Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
CA2842524C (en) 2011-07-22 2020-07-14 Massachusetts Institute Of Technology Activators of class i histone deacetylases (hdacs) and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2549118A (en) * 1949-10-05 1951-04-17 Us Rubber Co Vulcanized rubber and method of preserving same
CH301691A (de) * 1951-08-07 1954-09-15 Cilag Ag Verfahren zur Herstellung eines neuen aromatischen Thioäthers.
CH301687A (de) * 1951-08-07 1954-09-15 Cilag Ag Verfahren zur Herstellung eines neuen aromatischen Thioäthers.
CH301688A (de) * 1951-08-07 1954-09-15 Cilag Ag Verfahren zur Herstellung eines neuen aromatischen Thioäthers.
US3148997A (en) * 1963-01-04 1964-09-15 Dow Chemical Co Catechol compounds in improving clays and clay-containing materials
US3274257A (en) * 1963-06-17 1966-09-20 Dow Chemical Co Synthesis of (alkylthio) phenols
US3282979A (en) * 1963-06-17 1966-11-01 Dow Chemical Co Phenolic thioethers
GB1362782A (en) * 1970-08-26 1974-08-07 Fisons Ltd Tetrazole derivatives
US3751483A (en) * 1971-10-13 1973-08-07 Crown Zellerbach Corp Phenolic thioethers and process for preparing same
GB1428110A (en) * 1972-05-30 1976-03-17 Reckitt & Colmann Prod Ltd Pharmaceutical antihypertensive and vasodilator compositions
JPS506340A (no) * 1973-05-16 1975-01-23
DE2644591A1 (de) * 1976-10-02 1978-04-06 Bayer Ag Verfahren zur herstellung von arylsulfoniumsalzen
AU548253B2 (en) * 1981-05-11 1985-12-05 Pierre Fabre S.A. Benzoxepine derivatives and sulphur and nitrogen analogues thereof
US4661505A (en) * 1982-11-03 1987-04-28 Eli Lilly And Company Leukotriene antagonists
JPS60260532A (ja) * 1984-06-07 1985-12-23 Yamanouchi Pharmaceut Co Ltd 新規カテコ−ル誘導体
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers

Also Published As

Publication number Publication date
AT396469B (de) 1993-09-27
GB8623075D0 (en) 1986-10-29
DE3632841A1 (de) 1987-04-02
IE862533L (en) 1987-03-26
FI87646B (fi) 1992-10-30
NO170415B (no) 1992-07-06
FI84480B (fi) 1991-08-30
CA1278299C (en) 1990-12-27
DK457386A (da) 1987-03-27
NL189410B (nl) 1992-11-02
DK165115C (da) 1993-03-01
SE8603793L (sv) 1987-03-27
FR2587703B1 (fr) 1988-11-04
SE8603792D0 (sv) 1986-09-10
NO863834D0 (no) 1986-09-25
NO165238B (no) 1990-10-08
BE905432A (fr) 1987-03-16
IE59478B1 (en) 1994-03-09
PT83436A (en) 1986-10-01
NL189410C (nl) 1993-04-01
GB2181431B (en) 1989-09-20
FR2587698A1 (fr) 1987-03-27
US4699919A (en) 1987-10-13
NO863835L (no) 1987-03-27
OA08416A (fr) 1988-06-30
ZA866906B (en) 1987-04-29
SE467053B (sv) 1992-05-18
PT83437A (en) 1986-10-01
MY103521A (en) 1993-07-31
MY105863A (en) 1995-02-28
JPS6284080A (ja) 1987-04-17
MA20779A1 (fr) 1987-04-01
DK168334B1 (da) 1994-03-14
JPH0417956B2 (no) 1992-03-26
FR2587703A1 (fr) 1987-03-27
ES2001705A6 (es) 1988-06-01
US5013756A (en) 1991-05-07
AR241702A1 (es) 1992-11-30
IE59479B1 (en) 1994-03-09
FR2587699A1 (fr) 1987-03-27
TNSN86134A1 (fr) 1990-01-01
LU86590A1 (fr) 1987-01-22
FI84480C (fi) 1991-12-10
CH668261A5 (fr) 1988-12-15
ATA257386A (de) 1993-01-15
JPH0482129B2 (no) 1992-12-25
TNSN86135A1 (fr) 1990-01-01
MA20780A1 (fr) 1987-04-01
IE862532L (en) 1987-03-26
PT83437B (pt) 1988-07-29
NO165238C (no) 1991-01-16
FI863742A (fi) 1987-03-27
IT1235761B (it) 1992-09-28
FR2587702A1 (fr) 1987-03-27
SE464522B (sv) 1991-05-06
NO863835D0 (no) 1986-09-25
NL8602382A (nl) 1987-04-16
FI863742A0 (fi) 1986-09-16
AT402070B (de) 1997-01-27
FI863743A (fi) 1987-03-27
DK457486A (da) 1987-03-27
FI87646C (fi) 1993-02-10
CA1318686C (en) 1993-06-01
DE3632841C2 (no) 1992-06-11
FR2587702B1 (fr) 1988-11-04
GB8523776D0 (en) 1985-10-30
SG65889G (en) 1990-01-26
NL8602383A (nl) 1987-04-16
DK165115B (da) 1992-10-12
SE8603793D0 (sv) 1986-09-10
ZA866905B (en) 1987-04-29
LU86591A1 (fr) 1987-01-22
GB2181431A (en) 1987-04-23
PT83436B (pt) 1988-07-29
HK91289A (en) 1989-11-24
CH668421A5 (fr) 1988-12-30
HK46190A (en) 1990-06-22
AR242559A1 (es) 1993-04-30
FR2587698B1 (fr) 1989-04-28
NL189334C (nl) 1993-03-16
DK457486D0 (da) 1986-09-25
FI863743A0 (fi) 1986-09-16
GB8623074D0 (en) 1986-10-29
IT8621837A0 (it) 1986-09-26
SE8603792L (sv) 1987-03-27
IT1235760B (it) 1992-09-28
NO863834L (no) 1987-03-27
DE3632824C2 (no) 1992-04-30
IT8621836A0 (it) 1986-09-26
ATA257486A (de) 1996-06-15
OA08417A (fr) 1988-06-30
DZ991A1 (fr) 2004-09-13
DZ990A1 (fr) 2004-09-13
GB2189782A (en) 1987-11-04
DE3632824A1 (de) 1987-04-02
ES2001440A6 (es) 1988-05-16
BE905433A (fr) 1987-03-16
GB2189782B (en) 1989-04-12
JPS6284055A (ja) 1987-04-17
DK457386D0 (da) 1986-09-25
FR2587699B1 (fr) 1988-11-10

Similar Documents

Publication Publication Date Title
NO169493C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive peptid-derivater
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO170480C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO172801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater
NO841568L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO171638C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater
NO170726C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolinderivater
NO843979L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO169014C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive distamycinderivater
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO169438C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser
NO170482C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater
NO841542L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO171592C (no) Fremgangsmaate for fremstilling av aktive cinnolin-derivater
NO170582C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO168820C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzazepin-derivater
NO169648C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
NO169169C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte benzimidazoler
NO169652C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive guaninderivater